Advanced search×

This Week in JAMA

Author(s) unavailable

JAMA 305(18):1833 (2011)

DOI: 10.1001/jama.2011.607
Version: za2963e q8za0 q8zbc q8zc7 q8zd7 q8zec q8zfd q8zgc

Similar articles you may find interesting…

  1. In This Issue
    Author(s) unavailable

    Cell 145(4):0 (2011)

  2. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Samer S SS Najjar, Sunil V SV Rao, ...

    JAMA 305(18):1863-72 (2011) PMID 21558517

    Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function.
  3. This Week in JAMA
    Author(s) unavailable

    JAMA 305(19):1937 (2011)